Tirzepatide oral tablets: are they available in the UK?

Why can't I find tirzepatide oral tablets in the UK?

The short answer is that they don't exist here yet. Eli Lilly is developing an oral formulation of tirzepatide, and early-phase trial data have been published, but as of summer 2026 no oral tirzepatide tablet has been submitted for, let alone received, MHRA approval in the UK. The product is not on the market, cannot be prescribed, and cannot legally be dispensed by any UK pharmacy, whether on the high street or online.

This means any seller offering "oral tirzepatide tablets" or "tirzepatide pills" in the UK is operating outside the law. The MHRA has repeatedly warned about unlicensed weight-loss products sold through social media and unverified websites; buying medicines this way carries real clinical risk. You can report suspect sellers via the MHRA's Yellow Card scheme.

For now, the injectable Mounjaro pen is the only licensed UK form of tirzepatide. If you're exploring weight-management options, understanding what is genuinely available is the right starting point, and our weight-loss treatment overview maps out exactly that.

So what oral option IS licensed in the UK for weight loss?

The MHRA approved the Wegovy tablet (oral semaglutide) on 11 June 2026, making it the first oral GLP-1 medicine licensed anywhere in Europe for weight management. It contains semaglutide (the same active ingredient as the Wegovy injection) co-formulated with an absorption enhancer called SNAC. The dosing schedule runs from 1.5 mg through 4 mg and 9 mg up to a 25 mg maintenance dose, taken once daily first thing in the morning on an empty stomach.

Clinical trial data from the OASIS 4 study showed an average weight loss of around 13.6% over 64 weeks versus roughly 2.4% on placebo; among participants who adhered fully to the protocol, that figure reached approximately 16.6%. The MHRA's approval communications set out the licensed indication in full. It's worth knowing that Rybelsus (also oral semaglutide) carries different, lower doses (3 mg, 7 mg, 14 mg) and is licensed for type 2 diabetes rather than weight loss; those two products are not interchangeable.

Curious about how the injectable and oral options compare? Our overview of oral tirzepatide developments keeps track of what's in the pipeline.

How does injectable tirzepatide (Mounjaro) compare to the oral semaglutide that does exist?

This is a fair question to ask while oral tirzepatide is still in development. Mounjaro works on two gut-hormone pathways (GIP and GLP-1 receptors simultaneously) whereas semaglutide (injectable or tablet) targets only the GLP-1 receptor. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, tirzepatide at its highest dose produced around 20–21% average body-weight reduction over 72 weeks. The OASIS 4 trial's fully-adherent figure for oral semaglutide was roughly 16.6% over 64 weeks. Direct comparison is complicated by different trial designs, populations and durations, but the injectable tirzepatide data currently sit above the oral semaglutide data on average weight loss.

Whether that difference is clinically meaningful for a given individual, and which medicine suits them, is a prescriber's call. Someone who finds injections difficult may value the convenience of a daily tablet, even if the average loss figure differs. A prescriber takes those preferences alongside your health history, other medicines you take, and your BMI into account before recommending anything.

If oral semaglutide isn't yet available through your GP and you'd like to understand the private route, our page on tirzepatide oral tablets in the UK covers what to expect from a legitimate clinical pathway. And if cost is on your mind, our Mounjaro pricing guide explains what a transparent private prescription actually includes.

What should I do if I was searching for tirzepatide tablets?

It depends what prompted the search. If you're hoping to avoid injections, oral semaglutide is a genuine, licensed alternative worth discussing with a prescriber. If you're already established on Mounjaro injections and wondering about switching, that's a conversation for your current prescribing team, who can weigh your progress and tolerance.

If you were searching because you'd seen tirzepatide tablets advertised somewhere, treat that as a warning sign. No legitimate UK pharmacy can supply them, because they aren't licensed here. The MHRA's guidance is plain: only buy prescription medicines from a pharmacy you can verify on the GPhC register. Buying from an unverified source (especially something that doesn't legally exist in this market) puts you at significant risk. Worth a pause before clicking.

Our tirzepatide information hub covers everything about the licensed UK injection in one place, and our clinical team is available seven days a week. If you'd like a prescriber to review your situation and talk through which licensed option fits, you're welcome to speak to our prescribers through a free consultation, where we can also explain what ordering tirzepatide tablets online will look like once they reach the UK market.